Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38217,368,2.69 [2.01-3.61],2.737380728372302e-11
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,29274,1318,1.72 [1.46-2.03],6.223478555233372e-11
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39618,149,3.55 [2.28-5.54],2.148513455068852e-08
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43016,206,2.37 [1.62-3.47],9.809842395665827e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42942,132,3.44 [2.17-5.45],1.42734307469983e-07
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20218,586,2.29 [1.80-2.91],1.0791885086857992e-11
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,39862,1342,1.80 [1.54-2.11],2.798074833468978e-13
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),38767,765,1.91 [1.56-2.36],9.055166295343694e-10
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,40716,207,5.44 [3.77-7.84],1.0323628388503614e-19
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40696,187,5.53 [3.77-8.11],2.4568422879485992e-18
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,44183,68,6.05 [3.36-10.89],2.001062692527139e-09
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3799,68,4.75 [2.76-8.17],1.8709295917733805e-08
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",40452,68,6.68 [3.61-12.34],1.393028165645548e-09
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,31634,5592,1.42 [1.30-1.56],1.4850853575101808e-13
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43678,123,3.14 [1.94-5.09],3.3607094770436525e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,"Hypertension, essential",33358,3840,1.30 [1.17-1.45],1.0962825577962126e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Hypertension,33398,3880,1.32 [1.19-1.47],3.2352574595059306e-07
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29611,93,8.92 [5.29-15.01],1.9241126670859004e-16
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43308,194,3.24 [2.20-4.78],2.82026580492607e-09
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43523,406,2.32 [1.77-3.06],1.8049284041923087e-09
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Secondary right heart disease,43288,174,4.77 [3.22-7.06],6.942028783062862e-15
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,43290,176,4.74 [3.20-7.01],6.421857442956556e-15
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29685,167,5.14 [3.40-7.77],8.565637114828886e-15
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Conduction disorders,37320,208,2.71 [1.83-4.01],6.009272133926911e-07
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,25305,759,4.52 [3.64-5.63],8.620481091722578e-42
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37278,166,5.06 [3.37-7.60],4.907708858103407e-15
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42929,356,3.40 [2.55-4.54],1.0590919670329687e-16
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter X Diseases of the respiratory system,Other diseases of pleura,41368,415,1.94 [1.47-2.55],2.8773640033000146e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XI Diseases of the digestive system,Diseases of liver,43330,213,4.10 [2.86-5.88],2.0002501475191382e-14
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,32253,6945,1.41 [1.30-1.53],2.7544027817598268e-17
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,35069,4037,1.53 [1.39-1.69],9.237923290751396e-18
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31298,266,2.31 [1.64-3.26],1.7337321216723266e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,31829,797,1.96 [1.60-2.40],7.534449551153004e-11
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",44023,256,2.22 [1.57-3.14],6.774559963789209e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,44040,232,2.34 [1.63-3.36],4.4051291774733015e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,33023,1991,1.49 [1.30-1.70],1.0456203624149573e-08
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",37501,1991,1.43 [1.25-1.63],1.951495980330779e-07
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33284,2252,1.48 [1.31-1.68],9.715356214575475e-10
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43614,99,3.46 [2.01-5.95],7.421935138523336e-06
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,40406,372,3.17 [2.38-4.21],2.4780081837155066e-15
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Acute renal failure,40644,76,4.77 [2.63-8.68],2.9750377640208977e-07
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40666,98,8.73 [5.40-14.12],9.268836960258588e-19
